Global Peptide Therapeutics Market Insights, Forecast to 2025

1 Study Coverage

• 1.1 Peptide Therapeutics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type
  • 1.2.2 Injection
  • 1.2.3 Oral
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Peptide Therapeutics Market Size Growth Rate by Application
  • 1.3.2 Cancer
  • 1.3.3 Metabolic Disorders
  • 1.3.4 Central Nervous System
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Peptide Therapeutics Market Size Estimates and Forecasts
  • 2.1.1 Global Peptide Therapeutics Revenue 2015-2026
  • 2.1.2 Global Peptide Therapeutics Sales 2015-2026
• 2.2 Peptide Therapeutics Market Size by Region: 2020 Versus 2026
• 2.3 Peptide Therapeutics Sales by Region (2015-2026)
  • 2.3.1 Global Peptide Therapeutics Sales by Region: 2015-2020
  • 2.3.2 Global Peptide Therapeutics Sales Forecast by Region (2021-2026)
  • 2.3.3 Global Peptide Therapeutics Sales Market Share by Region (2015-2026)
• 2.4 Peptide Therapeutics Market Estimates and Projections by Region (2021-2026)
  • 2.4.1 Global Peptide Therapeutics Revenue by Region: 2015-2020
  • 2.4.2 Global Peptide Therapeutics Revenue Forecast by Region (2021-2026)
  • 2.4.3 Global Peptide Therapeutics Revenue Market Share by Region (2015-2026)

3 Global Peptide Therapeutics by Manufacturers

• 3.1 Global Top Peptide Therapeutics Manufacturers by Sales
  • 3.1.1 Global Peptide Therapeutics Sales by Manufacturer (2015-2020)
  • 3.1.2 Global Peptide Therapeutics Sales Market Share by Manufacturer (2015-2019)
• 3.2 Global Top Peptide Therapeutics Manufacturers by Revenue
  • 3.2.1 Global Peptide Therapeutics Revenue by Manufacturer (2015-2020)
  • 3.2.2 Global Peptide Therapeutics Revenue Share by Manufacturer (2015-2020)
• 3.3 Global Peptide Therapeutics Price by Manufacturer (2015-2020)
• 3.4 Competitive Landscape
  • 3.4.1 Key Peptide Therapeutics Manufacturers Covered: Ranking by Revenue
  • 3.4.2 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI) & (2015-2020)
  • 3.4.3 Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.5 Global Peptide Therapeutics Manufacturing Base Distribution, Product Type
  • 3.5.1 Peptide Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.5.2 Manufacturers Peptide Therapeutics Product Type
  • 3.5.3 Date of International Manufacturers Enter into Peptide Therapeutics Market
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

• 4.1 Sanofi
  • 4.1.1 Sanofi Corporation Information
  • 4.1.2 Sanofi Description, Business Overview
  • 4.1.3 Sanofi Peptide Therapeutics Products Offered
  • 4.1.4 Sanofi Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.1.5 Sanofi Peptide Therapeutics Revenue by Product
  • 4.1.6 Sanofi Peptide Therapeutics Revenue by Application
  • 4.1.7 Sanofi Peptide Therapeutics Revenue by Geographic Area
  • 4.1.8 Sanofi Peptide Therapeutics Revenue by Sales Channel
  • 4.1.9 Sanofi Recent Development
• 4.2 Eli Lilly
  • 4.2.1 Eli Lilly Corporation Information
  • 4.2.2 Eli Lilly Description, Business Overview
  • 4.2.3 Eli Lilly Peptide Therapeutics Products Offered
  • 4.2.4 Eli Lilly Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.2.5 Eli Lilly Peptide Therapeutics Revenue by Product
  • 4.2.6 Eli Lilly Peptide Therapeutics Revenue by Application
  • 4.2.7 Eli Lilly Peptide Therapeutics Revenue by Geographic Area
  • 4.2.8 Eli Lilly Peptide Therapeutics Revenue by Sales Channel
  • 4.2.9 Eli Lilly Recent Development
• 4.3 Novo Nordisk
  • 4.3.1 Novo Nordisk Corporation Information
  • 4.3.2 Novo Nordisk Description, Business Overview
  • 4.3.3 Novo Nordisk Peptide Therapeutics Products Offered
  • 4.3.4 Novo Nordisk Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.3.5 Novo Nordisk Peptide Therapeutics Revenue by Product
  • 4.3.6 Novo Nordisk Peptide Therapeutics Revenue by Application
  • 4.3.7 Novo Nordisk Peptide Therapeutics Revenue by Geographic Area
  • 4.3.8 Novo Nordisk Peptide Therapeutics Revenue by Sales Channel
  • 4.3.9 Novo Nordisk Recent Development
• 4.4 Takeda
  • 4.4.1 Takeda Corporation Information
  • 4.4.2 Takeda Description, Business Overview
  • 4.4.3 Takeda Peptide Therapeutics Products Offered
  • 4.4.4 Takeda Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.4.5 Takeda Peptide Therapeutics Revenue by Product
  • 4.4.6 Takeda Peptide Therapeutics Revenue by Application
  • 4.4.7 Takeda Peptide Therapeutics Revenue by Geographic Area
  • 4.4.8 Takeda Peptide Therapeutics Revenue by Sales Channel
  • 4.4.9 Takeda Recent Development
• 4.5 Teva
  • 4.5.1 Teva Corporation Information
  • 4.5.2 Teva Description, Business Overview
  • 4.5.3 Teva Peptide Therapeutics Products Offered
  • 4.5.4 Teva Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.5.5 Teva Peptide Therapeutics Revenue by Product
  • 4.5.6 Teva Peptide Therapeutics Revenue by Application
  • 4.5.7 Teva Peptide Therapeutics Revenue by Geographic Area
  • 4.5.8 Teva Peptide Therapeutics Revenue by Sales Channel
  • 4.5.9 Teva Recent Development
• 4.6 Novartis
  • 4.6.1 Novartis Corporation Information
  • 4.6.2 Novartis Description, Business Overview
  • 4.6.3 Novartis Peptide Therapeutics Products Offered
  • 4.6.4 Novartis Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.6.5 Novartis Peptide Therapeutics Revenue by Product
  • 4.6.6 Novartis Peptide Therapeutics Revenue by Application
  • 4.6.7 Novartis Peptide Therapeutics Revenue by Geographic Area
  • 4.6.8 Novartis Recent Development
• 4.7 AstraZeneca
  • 4.7.1 AstraZeneca Corporation Information
  • 4.7.2 AstraZeneca Description, Business Overview
  • 4.7.3 AstraZeneca Peptide Therapeutics Products Offered
  • 4.7.4 AstraZeneca Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.7.5 AstraZeneca Peptide Therapeutics Revenue by Product
  • 4.7.6 AstraZeneca Peptide Therapeutics Revenue by Application
  • 4.7.7 AstraZeneca Peptide Therapeutics Revenue by Geographic Area
  • 4.7.8 AstraZeneca Recent Development
• 4.8 Ipsen
  • 4.8.1 Ipsen Corporation Information
  • 4.8.2 Ipsen Description, Business Overview
  • 4.8.3 Ipsen Peptide Therapeutics Products Offered
  • 4.8.4 Ipsen Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.8.5 Ipsen Peptide Therapeutics Revenue by Product
  • 4.8.6 Ipsen Peptide Therapeutics Revenue by Application
  • 4.8.7 Ipsen Peptide Therapeutics Revenue by Geographic Area
  • 4.8.8 Ipsen Recent Development
• 4.9 AbbVie
  • 4.9.1 AbbVie Corporation Information
  • 4.9.2 AbbVie Description, Business Overview
  • 4.9.3 AbbVie Peptide Therapeutics Products Offered
  • 4.9.4 AbbVie Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.9.5 AbbVie Peptide Therapeutics Revenue by Product
  • 4.9.6 AbbVie Peptide Therapeutics Revenue by Application
  • 4.9.7 AbbVie Peptide Therapeutics Revenue by Geographic Area
  • 4.9.8 AbbVie Recent Development
• 4.10 Allergan
  • 4.10.1 Allergan Corporation Information
  • 4.10.2 Allergan Description, Business Overview
  • 4.10.3 Allergan Peptide Therapeutics Products Offered
  • 4.10.4 Allergan Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.10.5 Allergan Peptide Therapeutics Revenue by Product
  • 4.10.6 Allergan Peptide Therapeutics Revenue by Application
  • 4.10.7 Allergan Peptide Therapeutics Revenue by Geographic Area
  • 4.10.8 Allergan Recent Development
• 4.11 Ferring
  • 4.11.1 Ferring Corporation Information
  • 4.11.2 Ferring Description, Business Overview
  • 4.11.3 Ferring Peptide Therapeutics Products Offered
  • 4.11.4 Ferring Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.11.5 Ferring Peptide Therapeutics Revenue by Product
  • 4.11.6 Ferring Peptide Therapeutics Revenue by Application
  • 4.11.7 Ferring Peptide Therapeutics Revenue by Geographic Area
  • 4.11.8 Ferring Recent Development
• 4.12 Merck
  • 4.12.1 Merck Corporation Information
  • 4.12.2 Merck Description, Business Overview
  • 4.12.3 Merck Peptide Therapeutics Products Offered
  • 4.12.4 Merck Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.12.5 Merck Peptide Therapeutics Revenue by Product
  • 4.12.6 Merck Peptide Therapeutics Revenue by Application
  • 4.12.7 Merck Peptide Therapeutics Revenue by Geographic Area
  • 4.12.8 Merck Recent Development
• 4.13 J & J
  • 4.13.1 J & J Corporation Information
  • 4.13.2 J & J Description, Business Overview
  • 4.13.3 J & J Peptide Therapeutics Products Offered
  • 4.13.4 J & J Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.13.5 J & J Peptide Therapeutics Revenue by Product
  • 4.13.6 J & J Peptide Therapeutics Revenue by Application
  • 4.13.7 J & J Peptide Therapeutics Revenue by Geographic Area
  • 4.13.8 J & J Recent Development
• 4.14 The Medicines
  • 4.14.1 The Medicines Corporation Information
  • 4.14.2 The Medicines Description, Business Overview
  • 4.14.3 The Medicines Peptide Therapeutics Products Offered
  • 4.14.4 The Medicines Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  • 4.14.5 The Medicines Peptide Therapeutics Revenue by Product
  • 4.14.6 The Medicines Peptide Therapeutics Revenue by Application
  • 4.14.7 The Medicines Peptide Therapeutics Revenue by Geographic Area
  • 4.14.8 The Medicines Recent Development

5 Breakdown Data by Type

• 5.1 Global Peptide Therapeutics Sales by Type (2015-2026)
  • 5.1.1 Global Peptide Therapeutics Sales by Type (2015-2020)
  • 5.1.2 Global Peptide Therapeutics Sales Forecast by Type (2021-2026)
  • 5.1.3 Global Peptide Therapeutics Sales Market Share by Type (2015-2026)
• 5.2 Global Peptide Therapeutics Revenue Forecast by Type (2015-2026)
  • 5.2.1 Global Peptide Therapeutics Revenue by Type (2015-2020)
  • 5.2.2 Global Peptide Therapeutics Revenue Forecast by Type (2021-2026)
  • 5.2.3 Global Peptide Therapeutics Revenue Market Share by Type (2015-2026)
• 5.3 Peptide Therapeutics Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

• 6.1 Global Peptide Therapeutics Sales by Application (2015-2026)
  • 6.1.1 Global Peptide Therapeutics Sales by Application (2015-2020)
  • 6.1.2 Global Peptide Therapeutics Sales Forecast by Application (2021-2026)
  • 6.1.3 Global Peptide Therapeutics Sales Market Share by Application (2015-2026)
• 6.2 Global Peptide Therapeutics Revenue Forecast by Application (2015-2026)
  • 6.2.1 Global Peptide Therapeutics Revenue by Application (2015-2020)
  • 6.2.2 Global Peptide Therapeutics Revenue Forecast by Application (2021-2026)
  • 6.2.3 Global Peptide Therapeutics Revenue Market Share by Application (2015-2026)
• 6.3 Peptide Therapeutics Average Selling Price (ASP) by Application (2015-2026)

7 North America

• 7.1 North America Peptide Therapeutics Market Size YoY Growth 2015-2026
• 7.2 North America Peptide Therapeutics Market Facts & Figures by Country
  • 7.2.1 North America Peptide Therapeutics Sales by Country (2015-2026)
  • 7.2.2 North America Peptide Therapeutics Revenue by Country (2015-2026)
• 7.3 North America Peptide Therapeutics Sales by Type
• 7.4 North America Peptide Therapeutics Sales by Application

8 Asia-Pacific

• 8.1 Asia-Pacific Peptide Therapeutics Market Size YoY Growth 2015-2026
• 8.2 Asia-Pacific Peptide Therapeutics Market Facts & Figures by Region
  • 8.2.1 Asia-Pacific Peptide Therapeutics Sales by Region (2015-2026)
  • 8.2.2 Asia-Pacific Peptide Therapeutics Revenue by Region (2015-2026)
• 8.3 Asia-Pacific Peptide Therapeutics Sales by Type
• 8.4 Asia-Pacific Peptide Therapeutics Sales by Application

9 Europe

• 9.1 Europe Peptide Therapeutics Market Size YoY Growth 2015-2026
• 9.2 Europe Peptide Therapeutics Market Facts & Figures by Country
  • 9.2.1 Europe Peptide Therapeutics Sales by Country (2015-2026)
  • 9.2.2 Europe Peptide Therapeutics Revenue by Country (2015-2026)
• 9.3 Europe Peptide Therapeutics Sales by Type
• 9.4 Europe Peptide Therapeutics Sales by Application

10 Latin America

• 10.1 Latin America Peptide Therapeutics Market Size YoY Growth 2015-2026
• 10.2 Latin America Peptide Therapeutics Market Facts & Figures by Country
  • 10.2.1 Latin America Peptide Therapeutics Sales by Country (2015-2026)
  • 10.2.2 Latin America Peptide Therapeutics Revenue by Country (2015-2026)
• 10.3 Latin America Peptide Therapeutics Sales by Type
• 10.4 Latin America Peptide Therapeutics Sales by Application

11 Middle East and Africa

• 11.1 Middle East and Africa Peptide Therapeutics Market Size YoY Growth 2015-2026
• 11.2 Middle East and Africa Peptide Therapeutics Market Facts & Figures by Country
  • 11.2.1 Middle East and Africa Peptide Therapeutics Sales by Country (2015-2026)
  • 11.2.2 Middle East and Africa Peptide Therapeutics Revenue by Country (2015-2026)
• 11.3 Middle East and Africa Peptide Therapeutics Sales by Type
• 11.4 Middle East and Africa Peptide Therapeutics Sales by Application

12 Supply Chain and Sales Channel Analysis

• 12.1 Peptide Therapeutics Supply Chain Analysis
• 12.2 Peptide Therapeutics Key Raw Materials and Upstream Suppliers
• 12.3 Peptide Therapeutics Clients Analysis
• 12.4 Peptide Therapeutics Sales Channel and Sales Model Analysis
  • 12.4.1 Peptide Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 12.4.2 Peptide Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
  • 12.4.3 Peptide Therapeutics Distributors

13 Market Dynamics

• 13.1 Peptide Therapeutics Market Drivers
• 13.2 Peptide Therapeutics Market Opportunities
• 13.3 Peptide Therapeutics Market Challenges
• 13.4 Peptide Therapeutics Market Restraints
• 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details